Keywords: chiron, licenses, cubist, cubicin, corp, obtained, development

Chiron licenses Cubist's Cubicin

Article | 13 October 2003

Chiron Corp has obtained the development and commercialization rights for Cubist Pharmaceutical's antibiotic Cubicin (daptomycin for injection) in western and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Cubicin

Daptomycin Injection

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing